Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602

Author: Penna Giuseppa   Allegra Alessandro   Romeo Giuseppa   Alonci Andrea   Cannavò Antonino   Russo Sabina   D'Angelo Arianna   Petrungaro Annamaria   Musolino Caterina  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.51, Iss.7, 2012-09, pp. : 944-947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content